Global Blood Theraps Company Profile

✉ Email this page to a colleague

GLOBAL BLOOD THERAPS has two approved drugs.

There are ten US patents protecting GLOBAL BLOOD THERAPS drugs.

There are two hundred and forty-eight patent family members on GLOBAL BLOOD THERAPS drugs in thirty-nine countries and ten supplementary protection certificates in nine countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Global Blood Theraps	OXBRYTA	voxelotor	TABLET;ORAL	213137-002	Oct 14, 2022		RX	Yes	No	11,452,720	⤷ Try a Trial				⤷ Try a Trial
Global Blood Theraps	OXBRYTA	voxelotor	TABLET;ORAL	213137-002	Oct 14, 2022		RX	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Global Blood Theraps	OXBRYTA	voxelotor	TABLET, FOR SUSPENSION;ORAL	216157-001	Dec 17, 2021		RX	Yes	Yes	10,034,879	⤷ Try a Trial	Y	Y		⤷ Try a Trial
Global Blood Theraps	OXBRYTA	voxelotor	TABLET;ORAL	213137-001	Nov 25, 2019		RX	Yes	Yes	11,020,382	⤷ Try a Trial				⤷ Try a Trial
Global Blood Theraps	OXBRYTA	voxelotor	TABLET;ORAL	213137-001	Nov 25, 2019		RX	Yes	Yes	10,034,879	⤷ Try a Trial	Y	Y		⤷ Try a Trial
Global Blood Theraps	OXBRYTA	voxelotor	TABLET;ORAL	213137-001	Nov 25, 2019		RX	Yes	Yes	9,018,210	⤷ Try a Trial	Y	Y		⤷ Try a Trial
Global Blood Theraps	OXBRYTA	voxelotor	TABLET, FOR SUSPENSION;ORAL	216157-001	Dec 17, 2021		RX	Yes	Yes	11,452,720	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Australia	2014237361	⤷ Try a Trial
Eurasian Patent Organization	201591430	⤷ Try a Trial
Japan	6401772	⤷ Try a Trial
South Africa	201506433	⤷ Try a Trial
China	107176953	⤷ Try a Trial
Hungary	E035069	⤷ Try a Trial
Lithuania	PA2022517	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2797416	2022C/537	Belgium	⤷ Try a Trial	PRODUCT NAME: VOXELOTOR OU UN TAUTOMERE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/21/1622 20220215
2797416	CA 2022 00032	Denmark	⤷ Try a Trial	PRODUCT NAME: VOXELOTOR ELLER EN TAUTOMER ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1622 20220215
2797416	LUC00276	Luxembourg	⤷ Try a Trial	PRODUCT NAME: VOXELOTOR OR A TAUTOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AUTHORISATION NUMBER AND DATE: EU/1/21/1622 20220215
2797416	PA2022517	Lithuania	⤷ Try a Trial	PRODUCT NAME: VOKSELOTORAS ARBA TAUTOMERAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA ; REGISTRATION NO/DATE: EU/1/21/1622 20220214
2797416	CR 2022 00032	Denmark	⤷ Try a Trial	PRODUCT NAME: VOXELOTOR ELLER EN TAUTOMER ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1622 20220215
2797416	301191	Netherlands	⤷ Try a Trial	PRODUCT NAME: VOXELOTOR OF EEN TAUTOMEER OF FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/21/1622 20220215
2797416	122022000052	Germany	⤷ Try a Trial	PRODUCT NAME: VOXELOTOR ODER EIN TAUTOMER ODER PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1622 20220214
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.